AVITA Medical, Inc.
AVHHL
Get informed when a big investor buys or sells
+ FollowMarket Cap$469.53M
Close$
Share Statistics
| Market cap | $469.53 Million |
|---|---|
| Enterprise Value | $462.21 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.74 |
| Beta | 1.99 |
| Outstanding Shares | 30,749,894 |
Return
| Return on Equity | 154.76% |
|---|---|
| Return on Assets | -90.17% |
| Return on Invested Capital | 103.20% |
Valuation & Multiples
| P/E Ratio | -9.11 |
|---|---|
| PEG | 40.04 |
| Price to Sales | 0.98 |
| Price to Book Ratio | -1.96 |
| Enterprise Value to Revenue | 6.11 |
| Enterprise Value to EBIT | -21.39 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | -0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$19.92 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$21.92 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About AVITA Medical Inc
226 employees
CEO: Cary G. Vance AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a de...